IBDEI2KS ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43195,2)
 ;;=^5019543
 ;;^UTILITY(U,$J,358.3,43196,0)
 ;;=Z76.0^^195^2173^3
 ;;^UTILITY(U,$J,358.3,43196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43196,1,3,0)
 ;;=3^Issue of repeat prescription
 ;;^UTILITY(U,$J,358.3,43196,1,4,0)
 ;;=4^Z76.0
 ;;^UTILITY(U,$J,358.3,43196,2)
 ;;=^5063297
 ;;^UTILITY(U,$J,358.3,43197,0)
 ;;=Z04.8^^195^2173^1
 ;;^UTILITY(U,$J,358.3,43197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43197,1,3,0)
 ;;=3^Examination and observation for oth reasons
 ;;^UTILITY(U,$J,358.3,43197,1,4,0)
 ;;=4^Z04.8
 ;;^UTILITY(U,$J,358.3,43197,2)
 ;;=^5062665
 ;;^UTILITY(U,$J,358.3,43198,0)
 ;;=Z51.81^^195^2173^5
 ;;^UTILITY(U,$J,358.3,43198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43198,1,3,0)
 ;;=3^Therapeutic drug level monitoring
 ;;^UTILITY(U,$J,358.3,43198,1,4,0)
 ;;=4^Z51.81
 ;;^UTILITY(U,$J,358.3,43198,2)
 ;;=^5063064
 ;;^UTILITY(U,$J,358.3,43199,0)
 ;;=Z02.81^^195^2173^4
 ;;^UTILITY(U,$J,358.3,43199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43199,1,3,0)
 ;;=3^Paternity testing
 ;;^UTILITY(U,$J,358.3,43199,1,4,0)
 ;;=4^Z02.81
 ;;^UTILITY(U,$J,358.3,43199,2)
 ;;=^5062642
 ;;^UTILITY(U,$J,358.3,43200,0)
 ;;=Z02.79^^195^2173^2
 ;;^UTILITY(U,$J,358.3,43200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43200,1,3,0)
 ;;=3^Issue of other medical certificate
 ;;^UTILITY(U,$J,358.3,43200,1,4,0)
 ;;=4^Z02.79
 ;;^UTILITY(U,$J,358.3,43200,2)
 ;;=^5062641
 ;;^UTILITY(U,$J,358.3,43201,0)
 ;;=Y36.010S^^195^2174^1
 ;;^UTILITY(U,$J,358.3,43201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43201,1,3,0)
 ;;=3^War op involving explosion of depth-chg, milt, sequela
 ;;^UTILITY(U,$J,358.3,43201,1,4,0)
 ;;=4^Y36.010S
 ;;^UTILITY(U,$J,358.3,43201,2)
 ;;=^5061537
 ;;^UTILITY(U,$J,358.3,43202,0)
 ;;=Y36.050S^^195^2174^6
 ;;^UTILITY(U,$J,358.3,43202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43202,1,3,0)
 ;;=3^War op w acc deton onboard marine weapons, milt, sequela
 ;;^UTILITY(U,$J,358.3,43202,1,4,0)
 ;;=4^Y36.050S
 ;;^UTILITY(U,$J,358.3,43202,2)
 ;;=^5061561
 ;;^UTILITY(U,$J,358.3,43203,0)
 ;;=Y36.200S^^195^2174^5
 ;;^UTILITY(U,$J,358.3,43203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43203,1,3,0)
 ;;=3^War op involving unsp explosion and fragments, milt, sequela
 ;;^UTILITY(U,$J,358.3,43203,1,4,0)
 ;;=4^Y36.200S
 ;;^UTILITY(U,$J,358.3,43203,2)
 ;;=^5061609
 ;;^UTILITY(U,$J,358.3,43204,0)
 ;;=Y36.230S^^195^2174^7
 ;;^UTILITY(U,$J,358.3,43204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43204,1,3,0)
 ;;=3^War op w explosn of improv explosv device, milt, sequela
 ;;^UTILITY(U,$J,358.3,43204,1,4,0)
 ;;=4^Y36.230S
 ;;^UTILITY(U,$J,358.3,43204,2)
 ;;=^5061627
 ;;^UTILITY(U,$J,358.3,43205,0)
 ;;=Y36.250S^^195^2174^2
 ;;^UTILITY(U,$J,358.3,43205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43205,1,3,0)
 ;;=3^War op involving fragments from munitions, milt, sequela
 ;;^UTILITY(U,$J,358.3,43205,1,4,0)
 ;;=4^Y36.250S
 ;;^UTILITY(U,$J,358.3,43205,2)
 ;;=^5061639
 ;;^UTILITY(U,$J,358.3,43206,0)
 ;;=Y36.260S^^195^2174^8
 ;;^UTILITY(U,$J,358.3,43206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43206,1,3,0)
 ;;=3^War op w fragmt of improv explosv device, milt, sequela
 ;;^UTILITY(U,$J,358.3,43206,1,4,0)
 ;;=4^Y36.260S
 ;;^UTILITY(U,$J,358.3,43206,2)
 ;;=^5061645
 ;;^UTILITY(U,$J,358.3,43207,0)
 ;;=Y36.270S^^195^2174^3
 ;;^UTILITY(U,$J,358.3,43207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43207,1,3,0)
 ;;=3^War op involving fragments from weapons, milt, sequela
 ;;^UTILITY(U,$J,358.3,43207,1,4,0)
 ;;=4^Y36.270S
 ;;^UTILITY(U,$J,358.3,43207,2)
 ;;=^5061651
 ;;^UTILITY(U,$J,358.3,43208,0)
 ;;=Y36.290S^^195^2174^4
